Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients

Overview of attention for article published in Breast Cancer Research and Treatment, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 5 X users

patent: 1 patent

Citations

dimensions_citation: 74 Dimensions

Readers on

mendeley: 81 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHOD FOR PREDICTING THE RESPONSE TO CDK4/6 INHIBITOR THERAPY IN CANCER PATIENTS

Application WO-2022152899-A1

World Intellectual Property Organisation (WIPO)